Suspicious Cervical Cancer Lesions Follow up Adherence
Conditions
Brief summary
The goal of this pragmatic randomized control trial is to evaluate the effectiveness of three interventions in improving follow-up adherence among women treated for suspicious cervical lesions in primary healthcare settings in Ethiopia. The interventions include structured nurse-led telephone call reminders, home-visit reminders led by health extension workers, and application-based automated SMS text reminders. The main questions it aims to answer are: * Does structured nurse-led telephone call reminders improve follow-up adherence among women treated for suspicious cervical lesions compared to standard care? * Does home-reminder visits led by a Health Extension Worker (HEW) improve follow-up adherence among women treated for suspicious cervical lesions compared to standard care? * Does app-based automated SMS reminders improve follow-up adherence among women treated for suspicious cervical lesions compared to standard care? Structured Nurse-Led Telephone Call Reminders * Participants will receive proactive phone call reminders for scheduled follow-up visits. * The intervention includes three rounds: initially at 4 months post-recruitment, then every 4 months for HIV-negative women over a year, and every 2 months for 6 months for women living with HIV. Home-Reminder Visits Led by HEW Health Extension Workers (HEWs) will conduct door-to-door visits to remind participants of their scheduled follow-up appointments. • Door-to-door Visits will occur initially at 4 months (for HIV-negative women) and 2 months (for HIV-positive women) post-recruitment, then every 2 months for 6 months for HIV-positive and every 4 months for 12 months for HIV-negative participants. App-Based Automated SMS Reminders * Participants will receive SMS-based reminders for their follow-up visits. * The intervention consists of three rounds: initial texts at 4 months and 2 months post-recruitment for HIV-negative and HIV-positive women, respectively, followed by reminders every 2 months for 6 months for HIV-positive women and every 4 months for 12 months for HIV-negative women.
Interventions
Information already available
Sponsors
Study design
Eligibility
Inclusion criteria
* Women aged 30-49 (HIV-negative). * Women over 25 (HIV-positive). * Treated for suspicious cervical lesions after a positive VIA screening.
Exclusion criteria
* History of hysterectomy. * Diagnosis of other histological invasive cervical cancer. * Suspicious cervical cancer cases. * Pregnancy. * Prior screening history. * Vaginal bleeding. * Lack of consent.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Proportion of adherence to follow up recommendations in the intervention and standard group after suspicious cervical cancer lesion treatment. | re-screening (VIA) after one year (11-13 months) | Follow up adherence will be measured re-screening (VIA) after one year (11-13 months after first screening). We will use objective measurement thorough review of the comprehensive records maintained within the cervical cancer screening follow-up registry.Accordingly, women who fail to return for their scheduled follow-up visit will be categorized as Lost to Follow-Up, while those who do attend will be categorized as Follow-Up Adherent |
Countries
Ethiopia